サマリー

T細胞リンパ腫の世界市場 2022-2026 年
TechnavioはT細胞リンパ腫市場を監視しており、2022-2026年の間に76807万ドルの成長が見込まれ、予測期間中にCAGR 8.21%で加速しています。当レポートでは、T細胞リンパ腫市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、老年人口の増加、再発または難治性のT細胞リンパ腫患者に対する治療薬の承認の増加、T細胞リンパ腫の発生率の増加によって牽引されています。
T細胞リンパ腫の市場分析には、タイプ別セグメントと地理的展望が含まれます。
TechnavioのT細胞リンパ腫市場は、以下のように区分されています。
タイプ別
- 末梢性T細胞リンパ腫
- T細胞リンパ腫
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間におけるT細胞リンパ腫市場の成長を促進する主な理由の1つとして、技術的な進歩を挙げています。また、患者支援プログラムの増加や戦略的提携は、市場の大規模な需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。T細胞リンパ腫市場に関する当レポートの対象領域は次のとおりです。
- T細胞リンパ腫の市場サイジング
- T細胞リンパ腫の市場予測
- T細胞リンパ腫市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Accredo Health Group Inc.を含むいくつかのT細胞リンパ腫市場の主要ベンダーについて詳細な分析を行っています。AstraZeneca Plc、Autolus Therapeutics Plc、Baxter International Inc、Biogen Inc、Bristol Myers Squibb Co、Eli Lilly and Co、F. Hoffmann La Roche Ltd、Genmab AS、GSK Plc、H. Lee Moffitt Cancer Center and Research Institute Inc、Johnson and Johnson、Macopharma SAの各社、Merck and Co.Inc.、Mundipharma International Ltd.、Novartis AG、Pfizer Inc.、Sanofi、Teva Pharmaceutical Industries Ltd.、およびTYME Inc.です。また、T細胞リンパ腫の市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/t-cell-lymphoma-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。業界の主要な影響力を持つ人物を特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Peripheral T-cell lymphomas - Market size and forecast 2021-2026
o Exhibit 28: Chart on Peripheral T-cell lymphomas - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Peripheral T-cell lymphomas - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Peripheral T-cell lymphomas - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Peripheral T-cell lymphomas - Year-over-year growth 2021-2026 (%)
o 5.4 T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026
o Exhibit 32: Chart on T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on T-cell lymphoblastic lymphoma - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on T-cell lymphoblastic lymphoma - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 85: AbbVie Inc. - Overview
o Exhibit 86: AbbVie Inc. - Product / Service
o Exhibit 87: AbbVie Inc. - Key offerings
o 10.4 AstraZeneca Plc
o Exhibit 88: AstraZeneca Plc - Overview
o Exhibit 89: AstraZeneca Plc - Product / Service
o Exhibit 90: AstraZeneca Plc - Key news
o Exhibit 91: AstraZeneca Plc - Key offerings
o 10.5 Biogen Inc.
o Exhibit 92: Biogen Inc. - Overview
o Exhibit 93: Biogen Inc. - Product / Service
o Exhibit 94: Biogen Inc. - Key offerings
o 10.6 Bristol Myers Squibb Co.
o Exhibit 95: Bristol Myers Squibb Co. - Overview
o Exhibit 96: Bristol Myers Squibb Co. - Product / Service
o Exhibit 97: Bristol Myers Squibb Co. - Key offerings
o 10.7 F. Hoffmann La Roche Ltd.
o Exhibit 98: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 99: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 100: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 101: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 102: F. Hoffmann La Roche Ltd. - Segment focus
o 10.8 GSK Plc
o Exhibit 103: GSK Plc - Overview
o Exhibit 104: GSK Plc - Business segments
o Exhibit 105: GSK Plc - Key news
o Exhibit 106: GSK Plc - Key offerings
o Exhibit 107: GSK Plc - Segment focus
o 10.9 Johnson and Johnson
o Exhibit 108: Johnson and Johnson - Overview
o Exhibit 109: Johnson and Johnson - Business segments
o Exhibit 110: Johnson and Johnson - Key news
o Exhibit 111: Johnson and Johnson - Key offerings
o Exhibit 112: Johnson and Johnson - Segment focus
o 10.10 Merck and Co. Inc.
o Exhibit 113: Merck and Co. Inc. - Overview
o Exhibit 114: Merck and Co. Inc. - Business segments
o Exhibit 115: Merck and Co. Inc. - Key news
o Exhibit 116: Merck and Co. Inc. - Key offerings
o Exhibit 117: Merck and Co. Inc. - Segment focus
o 10.11 Novartis AG
o Exhibit 118: Novartis AG - Overview
o Exhibit 119: Novartis AG - Business segments
o Exhibit 120: Novartis AG - Key offerings
o Exhibit 121: Novartis AG - Segment focus
o 10.12 Pfizer Inc.
o Exhibit 122: Pfizer Inc. - Overview
o Exhibit 123: Pfizer Inc. - Product / Service
o Exhibit 124: Pfizer Inc. - Key news
o Exhibit 125: Pfizer Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 126: Inclusions checklist
o Exhibit 127: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 128: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 129: Research methodology
o Exhibit 130: Validation techniques employed for market sizing
o Exhibit 131: Information sources
o 11.5 List of abbreviations
o Exhibit 132: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Peripheral T-cell lymphomas - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Peripheral T-cell lymphomas - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Peripheral T-cell lymphomas - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Peripheral T-cell lymphomas - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on T-cell lymphoblastic lymphoma - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on T-cell lymphoblastic lymphoma - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on T-cell lymphoblastic lymphoma - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie Inc. - Overview
Exhibits86: AbbVie Inc. - Product / Service
Exhibits87: AbbVie Inc. - Key offerings
Exhibits88: AstraZeneca Plc - Overview
Exhibits89: AstraZeneca Plc - Product / Service
Exhibits90: AstraZeneca Plc - Key news
Exhibits91: AstraZeneca Plc - Key offerings
Exhibits92: Biogen Inc. - Overview
Exhibits93: Biogen Inc. - Product / Service
Exhibits94: Biogen Inc. - Key offerings
Exhibits95: Bristol Myers Squibb Co. - Overview
Exhibits96: Bristol Myers Squibb Co. - Product / Service
Exhibits97: Bristol Myers Squibb Co. - Key offerings
Exhibits98: F. Hoffmann La Roche Ltd. - Overview
Exhibits99: F. Hoffmann La Roche Ltd. - Business segments
Exhibits100: F. Hoffmann La Roche Ltd. - Key news
Exhibits101: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits102: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits103: GSK Plc - Overview
Exhibits104: GSK Plc - Business segments
Exhibits105: GSK Plc - Key news
Exhibits106: GSK Plc - Key offerings
Exhibits107: GSK Plc - Segment focus
Exhibits108: Johnson and Johnson - Overview
Exhibits109: Johnson and Johnson - Business segments
Exhibits110: Johnson and Johnson - Key news
Exhibits111: Johnson and Johnson - Key offerings
Exhibits112: Johnson and Johnson - Segment focus
Exhibits113: Merck and Co. Inc. - Overview
Exhibits114: Merck and Co. Inc. - Business segments
Exhibits115: Merck and Co. Inc. - Key news
Exhibits116: Merck and Co. Inc. - Key offerings
Exhibits117: Merck and Co. Inc. - Segment focus
Exhibits118: Novartis AG - Overview
Exhibits119: Novartis AG - Business segments
Exhibits120: Novartis AG - Key offerings
Exhibits121: Novartis AG - Segment focus
Exhibits122: Pfizer Inc. - Overview
Exhibits123: Pfizer Inc. - Product / Service
Exhibits124: Pfizer Inc. - Key news
Exhibits125: Pfizer Inc. - Key offerings
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations